Pavel Medvedev

Pavel Medvedev


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Daria TrushinaDaria Trushina
Daria Trushina
ASAnastasiia Yu. Sapach
Anastasiia Yu. Sapach
OBOlga Aleksandrovna Burachevskaia
Olga Aleksandrovna Burachevskaia
PMPavel Medvedev
Pavel Medvedev
DKDmitry N. Khmelenin
Dmitry N. Khmelenin
Vera V. ButovaVera V. Butova
Vera V. Butova
Beneficial features of biocompatible high-capacity UiO-66 nanoparticles, mesoporous SiO2, and folate-conjugated pluronic F127 were combined to prepare the core–shell UiO-66@SiO2/F127-FA drug delivery carrier for targeted cellular uptake in cancer treatment. UiO-66 and UiO-66-NH2 nanoparticles with a narrow size and shape distribution were used to form a series of core–shell MOF@SiO2 structures. The duration of silanization was varied to change the thickness of the SiO2 shell, revealing a nonlinear dependence that was attributed to silicon penetration into the porous MOF structure. Doxorubicin encapsulation showed a similar final loading of 5.6 wt % for both uncoated and silica-coated particles, demonstrating the potential of the nanocomposite’s application in small molecule delivery. Silica coating improved the colloidal stability of the composites in a number of model physiological media, enabled grafting of target molecules to the surface, and prevented an uncontrolled release of their cargo, with the drawback of decreased overall porosity. Further modification of the particles with the conjugate of pluronic and folic acid was performed to improve the biocompatibility, prolong the blood circulation time, and target the encapsulated drug to the folate-expressing cancer cells. The final DOX-loaded UiO-66@SiO2/F127-FA nanoparticles were subjected to properties characterization and in vitro evaluation, including studies of internalization into cells and antitumor activity. Two cell lines were used: MCF-7 breast cancer cells, which have overexpressed folate receptors on the cell membranes, and RAW 264.7 macrophages without folate overexpression. These findings will provide a potential delivery system for DOX and increase the practical value of MOFs.

1 September 2018 in JETP Letters
Verified
Journal Article
Closed access
PDF file
PMPavel Medvedev
Pavel Medvedev
MSM. A. Soldatov
M. A. Soldatov
VSVictor Shapovalov
Victor Shapovalov
ATAndrei Tereshchenko
Andrei Tereshchenko
IGI. E. Gorban’
I. E. Gorban’
Alexander SoldatovAlexander Soldatov
Alexander Soldatov
Experimental X-ray absorption spectra near the Fe Kedge for as-synthesized MIL-88а metal–organic framework (MIL stands for Materials Institute Lavoisier) before and after activation have been...

1 November 2019 in Journal of Surface Investigation: X-Ray, Synchrotron and Neutron Techniques
Verified
Journal Article
Closed access
PDF file
MSMikhail Soldatov
Mikhail Soldatov
PMPavel Medvedev
Pavel Medvedev
SWS. Wei
S. Wei
Alexander SoldatovAlexander Soldatov
Alexander Soldatov
— The geometric and band structures of cobalt-metahydroxide nanosheets, which are related to a new class of two-dimensional nanocatalysts for the hydrogen-release reaction, are calculated. As...